Publications

The Framework for collaborative action on TB and comorbidities aims to support countries in the evidence-informed introduction and scale-up of holistic people-centred services for TB, comorbidities and health-related risk factors, with the goal of comprehensively addressing TB and other co-existing health conditions. It should be used in conjunction with relevant WHO guidelines. ties. The Framework is intended for use by people working in ministries of health, other relevant line-ministries, policymakers, international technical and funding organizations, researchers, nongovernmental and civil society organizations, as well as primary care workers, specialist health practitioners, and community health workers who support the response to TB and comorbidities in both the public and private sectors.

The Global Plan to End TB, 2023–2030 (Global Plan) is a plan for ending tuberculosis (TB) as a public health challenge by 2030—the year by which governments around the world have committed to achieving the United Nations (UN) Sustainable Development Goals. This document provides the most detailed costing estimates of any Global Plan to date and builds on the previous edition, Paradigm Shift, which laid out priority actions for 2018–2022 informed by global commitments endorsed by Member States at the 2018 UN High-Level Meeting (UNHLM) on TB. This Global Plan anticipates the priority actions that will be necessary in the wake of the COVID-19 pandemic and informs follow-up commitments to be made at a second UNHLM on TB in 2023.

This document is one of a series spotlighting the experiences of these early implementers when using artificial intelligence (AI) / computer-aided detection (CAD), to highlight the added value of CAD for TB programmes and inspire prospective implementers to innovate. Funding of this project was provided by the Stop TB Partnership’s TB REACH initiative, launched in 2010 by Global Affairs Canada. In 2012, TB REACH first worked with implementing partners to pilot CAD software.

Progress on the Sustainable Development Goals: The gender snapshot 2022 presents the latest evidence on gender equality across all 17 Goals, calling out the long road ahead to achieve gender equality. It emphasizes the interlinkages among the goals, the pivotal force gender equality plays in driving progress across the SDGs, and women and girls’ central role in leading the way forward.  

This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed structure of the NSP. The target audience of this publication are all stakeholders involved in national strategic planning for TB (e.g., ministry of health, other government ministries, private sector, civil society, affected communities, academic and research institutions, and technical and funding partners).

The purpose of this document is to describe and explain how to apply the principles of good clinical practice (GCP) and good data management practice (GDMP) in the context of national tuberculosis (TB) surveys, namely national population-based surveys of TB prevalence, anti-TB drug resistance surveys, and surveys of costs faced by TB patients and their households.

In July 2022, there were 1,346 confirmed HIV-positive individuals reported to the HIV/AIDS & ART Registry of the Philippines (HARP) and were accounted to the total (103,112) reported cases since January 1984. Moreover, 30% (399) of individuals reported in July had advanced HIV infection (217 based on immunologic criterion, additional 182 based on clinical criteria) at the time of testing. Seventy deaths were newly reported, bringing the total deaths this year to 318. 

In June 2022, there were 1,472 confirmed HIV-positive individuals reported to the HIV/AIDS & ART Registry of the Philippines (HARP). This was a 2% increase compared to the same reporting period last year (1,495). Twenty-five percent (372) had clinical manifestations of advanced HIV infection at the time of testing.

In May 2022, there were 1,308 confirmed HIV-positive individuals reported to the HIV/AIDS & ART Registry of the Philippines (HARP) and were accounted to the total (100,298) reported cases since January 1984. Moreover, 30% (392) of individuals reported in May had advanced HIV infection (214 based on immunologic criterion, additional 178 based on clinical criteria) at the time of testing. Thirteen deaths were reported in this reporting period bringing the total of 214 this year.

In April 2022, there were 1,198 confirmed HIV-positive individuals reported to the HIV/AIDS & ART Registry of the Philippines (HARP) and were accounted to the total (98,990) reported cases since January 1984. Moreover, 29% (350) of individuals reported in April had advanced HIV infection (174 based on immunologic criterion, additional 176 based on clinical criteria) at the time of testing. Thirteen deaths were reported in this reporting period bringing the total of 189d this year.